Hm Payson & CO Voyager Therapeutics, Inc. Transaction History
Hm Payson & CO
- $6.76 Billion
- Q3 2025
A detailed history of Hm Payson & CO transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Hm Payson & CO holds 1,500 shares of VYGR stock, worth $6,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,000
50.0%
Holding current value
$6,000
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VYGR
# of Institutions
113Shares Held
32.5MCall Options Held
32.9KPut Options Held
22.7K-
Black Rock Inc. New York, NY5.31MShares$21.3 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.8MShares$19.2 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.25MShares$13 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY1.48MShares$5.9 Million0.24% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.28MShares$5.13 Million0.0% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $155M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...